unknown
Stage
About
IMEL Biotherapeutics is developing a cell-based therapy using proprietary Mitochondrial Replaced Cells technology to treat patients with mitochondrial genetic or age-related disorders.
Explore IMEL Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.